kanamycin


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to kanamycin: chloramphenicol, Kanamycin sulfate

kan·a·my·cin

 (kăn′ə-mī′sĭn)
n.
A broad-spectrum antibiotic, C18H36N4O11, obtained from the soil bacterium Streptomyces kanamyceticus and used to treat a variety of bacterial infections, usually in its sulfate form.

[New Latin kanamyc(ēticus), specific epithet (Japanese kana-, golden (from the color of its colonies), combining form of kane, gold (possibly of late Old Chinese origin and akin to Mandarin jīn, and Cantonese gam1, gold) + New Latin mycēticus, fungus, from -mycētēs; see -mycete) + -in.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

kanamycin

(ˌkænəˈmaɪsɪn)
n
(Pharmacology) an aminoglycoside antibiotic obtained from the soil bacterium Streptomyces kanamyceticus, used in the treatment of various infections, esp those caused by Gram-negative bacteria. Formula: C18H36N4O11
[C20: from New Latin kanamyceticus]
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.kanamycin - antibiotic (trade name Kantrex) used to treat severe infections
antibiotic, antibiotic drug - a chemical substance derivable from a mold or bacterium that can kill microorganisms and cure bacterial infections; "when antibiotics were first discovered they were called wonder drugs"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations
kanamicina
References in periodicals archive ?
Regenerants with kanamycin resistance were assessed by PCR to determine the presence of the nptII gene (Fig.
The second XDR isolate (from a patient previously treated in Papua New Guinea) had a p.Asp89Asn gyrA mutation and phenotypic kanamycin resistance without a detected mutation conferring aminoglycoside resistance.
htm), which identified mutations consistent with resistance to HRZE, fluoroquinolones, and the injectable aminoglycosides amikacin, kanamycin, and capreomycin.
Antimicrobial susceptibility was determined using the disc diffusion method (Kirby-Bauer) against gentamicin (10 [micro]g), amikacin (30 [micro]g), kanamycin (30 [micro]g), and tobramycin (10 [micro]g) (Mast, England) according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI).
Least resistance was shown to amino glycosides (kanamycin, gentamicin and amikacin) and sulfonamides (combination of sulphadimidine, sulphadiazine and sulphathiazole).
pneumoniae isolates to aminoglycoside such as tobramycin (10 mg), gentamicin (10 mg), amikacin (30 mg) and kanamycin (5 mg) was performed using disk diffusion method (Kirby-Bauer) (Liofilchem, Italy) recommended by Clinical and Laboratory Standard Institute (CLSI) guideline (14).
coli showed resistance to antibiotics like ampicillin (70%), sulfamethoxazole-trimethoprim (60%), clindamycin (80%), erythromycin (60%), chloramphenicol (50%), and kanamycin (50%).
The more permeable membrane would now allow compounds such as rifampin, erythromycin and kanamycin into the cell.
The results showed that various optimal parameters such as 100 mg L-1 of kanamycin concentration for selection of transformants, 2 d of pre-cultivation time, 100 umol L-1 of acetosyringone concentration, 15 min of infection time and 2 d of co-cultivation time were obtained using cotyledonary node explants.
InKlebsiellaTn1331 and Tn4401 has stated to carry Amikacin, Ampicillin, Kanamycin, Streptomycin, Tobramycin and [beta]-lactamases.
For the susceptibility testing, the following 14 antimicrobial drugs and concentrations were used: ampicillin (10 [micro]g), amoxicillin (20 [micro]g), cefoxitin (30 [micro]g), chloramphenicol (30 [micro]g), ciprofloxacin (5 [micro]g), clindamycin (30 [micro]g), erythromycin (15 [micro]g), gentamycin (10 [micro]g), kanamycin (30 [micro]g), nalidixic acid (30 [micro]g), spectinomycin (30 [micro]g), streptomycin (10 [micro]g), tetracycline (30 [micro]g), and trimethoprim (5 [micro]g) (Oxoid Ltd., Cambridge, UK).